NextCure Archives · BioBuzz

Loading …

Maryland Startup Apsis Healthcare Systems Striving to Simplify Drug Development Where Technology and Biology Meet

<img width="300" height="300" alt="" data-srcset="https://biobuzz.io/wp-content/uploads/2020/09/Apsis-Healthcare-featured-img-300x300.png 300w, https://biobuzz.io/wp-content/uploads/2020/09/Apsis-Healthcare-featured-img-150x150.png 150w, https://biobuzz.io/wp-content/uploads/2020/09/Apsis-Healthcare-featured-img-75x75.png 75w" data-src="https://biobuzz.io/wp-content/uploads/2020/09/Apsis-Healthcare-featured-img-300x300.png" data-sizes="(max-width: 300px) 100vw, 300px" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image lazyload lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img width="300" height="300" src="https://biobuzz.io/wp-content/uploads/2020/09/Apsis-Healthcare-featured-img-300x300.png" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image lazyload" alt="" srcset="https://biobuzz.io/wp-content/uploads/2020/09/Apsis-Healthcare-featured-img-300x300.png 300w, https://biobuzz.io/wp-content/uploads/2020/09/Apsis-Healthcare-featured-img-150x150.png 150w, https://biobuzz.io/wp-content/uploads/2020/09/Apsis-Healthcare-featured-img-75x75.png 75w" sizes="(max-width: 300px) 100vw, 300px" />

Published on : September 29, 2020September 29, 2020 Published by : Steven Surdez

University of Maryland alumni, Sathya Janardhanan, founded Apsis Healthcare Systems in 2018 to help biotech and pharma companies of all sizes simplify drug development through process automation and leveraging the power of Big Data.

BioHealth Capital Region Startups Raised More Than $739M in 2019

<img width="300" height="300" alt="" data-srcset="https://biobuzz.io/wp-content/uploads/2019/12/Top-Investments-1-300x300.png 300w, https://biobuzz.io/wp-content/uploads/2019/12/Top-Investments-1-100x100.png 100w, https://biobuzz.io/wp-content/uploads/2019/12/Top-Investments-1-150x150.png 150w, https://biobuzz.io/wp-content/uploads/2019/12/Top-Investments-1-75x75.png 75w" data-src="https://biobuzz.io/wp-content/uploads/2019/12/Top-Investments-1-300x300.png" data-sizes="(max-width: 300px) 100vw, 300px" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image lazyload lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img width="300" height="300" src="https://biobuzz.io/wp-content/uploads/2019/12/Top-Investments-1-300x300.png" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image lazyload" alt="" srcset="https://biobuzz.io/wp-content/uploads/2019/12/Top-Investments-1-300x300.png 300w, https://biobuzz.io/wp-content/uploads/2019/12/Top-Investments-1-100x100.png 100w, https://biobuzz.io/wp-content/uploads/2019/12/Top-Investments-1-150x150.png 150w, https://biobuzz.io/wp-content/uploads/2019/12/Top-Investments-1-75x75.png 75w" sizes="(max-width: 300px) 100vw, 300px" />

Published on : December 17, 2019December 17, 2019 Published by : Chris Frew

BioHealth Capital Region Startups Raised More Than $739M in 2019 These 15 Biohealth Startups had a Banner Year, Setting Themselves Up for Success in 2020 The startup ecosystem in the [….]

Serial Entrepreneurs of the Biohealth Capital Region

<img width="300" height="300" alt="" data-srcset="https://biobuzz.io/wp-content/uploads/2019/09/Serial-Entrepreneurs-of-the-Biohealth-Capital-Region-300x300.png 300w, https://biobuzz.io/wp-content/uploads/2019/09/Serial-Entrepreneurs-of-the-Biohealth-Capital-Region-100x100.png 100w, https://biobuzz.io/wp-content/uploads/2019/09/Serial-Entrepreneurs-of-the-Biohealth-Capital-Region-150x150.png 150w, https://biobuzz.io/wp-content/uploads/2019/09/Serial-Entrepreneurs-of-the-Biohealth-Capital-Region-75x75.png 75w" data-src="https://biobuzz.io/wp-content/uploads/2019/09/Serial-Entrepreneurs-of-the-Biohealth-Capital-Region-300x300.png" data-sizes="(max-width: 300px) 100vw, 300px" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image lazyload lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img width="300" height="300" src="https://biobuzz.io/wp-content/uploads/2019/09/Serial-Entrepreneurs-of-the-Biohealth-Capital-Region-300x300.png" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image lazyload" alt="" srcset="https://biobuzz.io/wp-content/uploads/2019/09/Serial-Entrepreneurs-of-the-Biohealth-Capital-Region-300x300.png 300w, https://biobuzz.io/wp-content/uploads/2019/09/Serial-Entrepreneurs-of-the-Biohealth-Capital-Region-100x100.png 100w, https://biobuzz.io/wp-content/uploads/2019/09/Serial-Entrepreneurs-of-the-Biohealth-Capital-Region-150x150.png 150w, https://biobuzz.io/wp-content/uploads/2019/09/Serial-Entrepreneurs-of-the-Biohealth-Capital-Region-75x75.png 75w" sizes="(max-width: 300px) 100vw, 300px" />

Published on : September 17, 2019September 24, 2020 Published by : Chris Frew

Serial Entrepreneurs of the Biohealth Capital Region A strong group of entrepreneurs ready and willing to innovate, fund and lead new bioscience companies is essential to the creation and sustainability [….]

NextCure files for $92M IPO to advance Cancer Immunotherapy Pipeline

<img width="300" height="300" alt="" data-srcset="https://biobuzz.io/wp-content/uploads/2019/04/NextCure-logo-300x300.jpg 300w, https://biobuzz.io/wp-content/uploads/2019/04/NextCure-logo-100x100.jpg 100w, https://biobuzz.io/wp-content/uploads/2019/04/NextCure-logo-150x150.jpg 150w, https://biobuzz.io/wp-content/uploads/2019/04/NextCure-logo-75x75.jpg 75w" data-src="https://biobuzz.io/wp-content/uploads/2019/04/NextCure-logo-300x300.jpg" data-sizes="(max-width: 300px) 100vw, 300px" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image lazyload lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img width="300" height="300" src="https://biobuzz.io/wp-content/uploads/2019/04/NextCure-logo-300x300.jpg" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image lazyload" alt="" srcset="https://biobuzz.io/wp-content/uploads/2019/04/NextCure-logo-300x300.jpg 300w, https://biobuzz.io/wp-content/uploads/2019/04/NextCure-logo-100x100.jpg 100w, https://biobuzz.io/wp-content/uploads/2019/04/NextCure-logo-150x150.jpg 150w, https://biobuzz.io/wp-content/uploads/2019/04/NextCure-logo-75x75.jpg 75w" sizes="(max-width: 300px) 100vw, 300px" />

Published on : April 29, 2019April 30, 2019 Published by : Chris Frew

NextCure files for $92M IPO to advance Cancer Immunotherapy Pipeline April 29, 2019 NextCure, a clinical-stage biotech in Beltsville, MD developing cancer immunotherapies, announced the terms for its IPO that [….]

BioHealth Capital Region is Entering Period of “Creative Destruction” at Perfect Time

<img width="300" height="300" alt="" data-srcset="https://biobuzz.io/wp-content/uploads/2019/03/2-300x300.png 300w, https://biobuzz.io/wp-content/uploads/2019/03/2-e1552452464153-100x100.png 100w, https://biobuzz.io/wp-content/uploads/2019/03/2-150x150.png 150w, https://biobuzz.io/wp-content/uploads/2019/03/2-e1552452464153-75x75.png 75w" data-src="https://biobuzz.io/wp-content/uploads/2019/03/2-300x300.png" data-sizes="(max-width: 300px) 100vw, 300px" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image lazyload lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img width="300" height="300" src="https://biobuzz.io/wp-content/uploads/2019/03/2-300x300.png" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image lazyload" alt="" srcset="https://biobuzz.io/wp-content/uploads/2019/03/2-300x300.png 300w, https://biobuzz.io/wp-content/uploads/2019/03/2-e1552452464153-100x100.png 100w, https://biobuzz.io/wp-content/uploads/2019/03/2-150x150.png 150w, https://biobuzz.io/wp-content/uploads/2019/03/2-e1552452464153-75x75.png 75w" sizes="(max-width: 300px) 100vw, 300px" />

Published on : March 13, 2019March 14, 2019 Published by : Steven Surdez

BioHealth Capital Region is Entering Period of “Creative Destruction” at Perfect Time March 12, 2019 In 1942, Austrian economist Joseph Schumpeter wrote, “ …industrial mutation—if I may use that biological [….]